Making diabetes outcomes available
At Promptly, we are empowering patients with digital tools that can help them manage their disease outcomes. Proempower is part of that challenge. A group of Portuguese, Greek, Turkish, Italian and Swiss companies, research labs and patient associations joined forces in developing innovative solutions for patients with type 2 diabetes.
For the next two years, we will be pilot testing a comprehensive diabetes system in Portugal, Spain, Italy and Turkey. Stay tuned in the developments of this project and get to know more in our website.